Antenatal depression, psychotropic medication use, and inflammation among pregnant women
Miller E, Grobman W, Culhane J, Adam E, Buss C, Entringer S, Miller G, Wadhwa P, Keenan-Devlin L, Borders A. Antenatal depression, psychotropic medication use, and inflammation among pregnant women. Archives Of Women's Mental Health 2018, 21: 785-790. PMID: 29862416, PMCID: PMC6240365, DOI: 10.1007/s00737-018-0855-9.Peer-Reviewed Original ResearchConceptsAntenatal depressive symptomsInflammatory biomarkersPregnant womenProspective multicenter observational studyCross-sectional secondary analysisContext of pharmacotherapyHigher TNFα levelsMulticenter observational studyEpidemiologic Studies Depression ScalePsychotropic medication useLower TNFαPre-existing high levelsAntenatal depressionMedication useSerum TNFαTNFα levelsWeeks' gestationSelf-reported useDepression screenPsychotropic medicationsTNFα concentrationsMedical recordsPoor responseTherapeutic responseObservational study